Navega Therapeutics has developed a patented, non-permanent gene therapy to target pain that is non-addictive, highly specific, and long-lasting. Navega Therapeutics has imitated this process by utilizing a novel gene therapy to target pain in a non-permanent way.

Biotechnology

Navega Therapeutics

Ana Moreno

Fernando Aleman

The founding team at Navega Therapeutics have a long history of experience in research and engineering, with many of them having worked together in the past. They have a wide range of educational backgrounds, from electrical engineering to business administration, which gives them the skills necessary to develop and commercialize their products.

Founding Team

About

Team members

Other teams at Navega Therapeutics

Board of Directors

Leadership Team